EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...
GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...
MILLIONS of Brits with asthma are potentially risking their lives by not using their inhaler properly, UK experts have warned The UK has one worst death rates from the lung condition in ...
Whether inhaled corticosteroids (ICSs) should be prescribed to people with chronic obstructive ... We also conducted sensitivity analyses, including: (1) HES-defined MACEs only and (2) patients with ...
There are three types of allergies: ingested allergies, contact allergies, and inhaled allergies ... mites Many people confuse hay fever with asthma. Asthma is a chronic inflammatory disorder ...
A person may be able to treat eczema without steroids. Possible treatment options include topical calcineurin inhibitors, crisaborole, JAK inhibitors, and more. Corticosteroids (steroids ...
They are preferred when inhaled steroids do not adequately control symptoms. LABAs are not used as a single asthma medication but as an add-on therapy and often are combined with another asthma ...